Benitec Biopharma
BNTC
$8.87
Share price
7.89%
Change (1 day)
4,334.30%
Change (1 year)
Revenue for Benitec Biopharma (BNTC)
Revenue in 2023 (TTM): $0.06 M
According to Benitec Biopharma
's latest financial reports the company's current revenue (TTM
) is $0.06 M.
a decrease over the years 2022 revenue that were of $0.06 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Benitec Biopharma from 2015 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 | $0.06 M | -1.61% |
| 2022 | $0.06 M | 121.43% |
| 2021 | $0.02 M | -36.36% |
| 2020 | $0.04 M | |
| 2017 | $0.45 M | 106.03% |
| 2016 | $0.22 M | -44.59% |
| 2015 | $0.4 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | N/A | N/A | Bahamas |
 NRC Health
NRC | $0.14 B | 243,473.77% | 🇺🇸 USA |